Cellular Physiology and Biochemistry· 2013Q3
Skepinone-L, a Novel Potent and Highly Selective Inhibitor of p38 MAP Kinase, Effectively Impairs Platelet Activation and Thrombus Formation
- 1,863citations
- Q3SCImago
- 2013year
Short summary
Skepinone-L, a novel p38 MAP kinase inhibitor, significantly reduced platelet activation and thrombus formation in human platelets by blocking p38 MAPK-dependent synthesis of thromboxane A2.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Hematology
HematologyMedicine